149 related articles for article (PubMed ID: 34026204)
21. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.
Locatelli F; Algeri M; Merli P; Strocchio L
Expert Rev Hematol; 2018 Feb; 11(2):129-143. PubMed ID: 29279013
[TBL] [Abstract][Full Text] [Related]
22. [Allopurinol-induced DRESS complicated by hemophagocytic lymphohistiocytosis].
Korbi M; Youssef M; Ben Brahim H; Chaabane A; Mohamed M; Akkari H; Belhadjali H; Zili J
Ann Dermatol Venereol; 2015 Dec; 142(12):767-70. PubMed ID: 25982828
[TBL] [Abstract][Full Text] [Related]
23. Post-Transfusion Hemophagocytosis Without Hemophagocytic Lymphohistiocytosis.
McGinnis E; Medvedev N; Richards MJ; Chen LYC; Wong MP
Mayo Clin Proc Innov Qual Outcomes; 2019 Dec; 3(4):517-522. PubMed ID: 31993572
[TBL] [Abstract][Full Text] [Related]
24. [Juvenile myelomonocytic leukemias].
Lachenaud J; Strullu M; Baruchel A; Cavé H
Bull Cancer; 2014 Mar; 101(3):302-13. PubMed ID: 24691193
[TBL] [Abstract][Full Text] [Related]
25. Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report.
Yao R; Yu T; Xu Y; Li G; Yin L; Zhou Y; Wang J; Yan Z
BMC Med Genomics; 2018 Jul; 11(1):60. PubMed ID: 30012129
[TBL] [Abstract][Full Text] [Related]
26. Abnormal B-Cell Maturation and Increased Transitional B Cells in CBL Syndrome.
Saettini F; Coliva TA; Vendemini F; Galbiati M; Bugarin C; Masetti R; Moratto D; Chiarini M; Guerra F; Iascone M; Badolato R; Cazzaniga G; Niemeyer C; Flotho C; Biondi A
Front Pediatr; 2022; 10():935951. PubMed ID: 35967575
[TBL] [Abstract][Full Text] [Related]
27. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
Niemeyer CM; Flotho C
Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
[TBL] [Abstract][Full Text] [Related]
28. Osteopetrosis mimicking juvenile myelomonocytic leukemia.
Hoyoux C; Dresse MF; Forget P; Piette C; Rausin L; Villa A; Gothot A; Florkin B
Pediatr Int; 2014 Oct; 56(5):779-82. PubMed ID: 25335998
[TBL] [Abstract][Full Text] [Related]
29. Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant.
Ji J; Navid F; Hiemenz MC; Kaneko M; Zhou S; Saitta SC; Biegel JA
Cancer Genet; 2019 Feb; 231-232():62-66. PubMed ID: 30803559
[TBL] [Abstract][Full Text] [Related]
30. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
[No Abstract] [Full Text] [Related]
31. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?
Grom AA
Curr Opin Rheumatol; 2003 Sep; 15(5):587-90. PubMed ID: 12960485
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of the criteria for hemophagocytic lymphohistiocytosis.
Aksionau A; Wei EX
Int J Clin Exp Pathol; 2020; 13(12):3139-3148. PubMed ID: 33425114
[TBL] [Abstract][Full Text] [Related]
33. Origin of macrophages involved in the development of allogeneic hematopoietic stem cell transplantation-associated hemophagocytic syndrome: observations on a patient with juvenile myelomonocytic leukemia.
Ishida H; Yoshida H; Yoshihara T; Ito M; Morimoto A
Bone Marrow Transplant; 2007 Oct; 40(7):701-3. PubMed ID: 17646843
[No Abstract] [Full Text] [Related]
34. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Tamamyan GN; Kantarjian HM; Ning J; Jain P; Sasaki K; McClain KL; Allen CE; Pierce SA; Cortes JE; Ravandi F; Konopleva MY; Garcia-Manero G; Benton CB; Chihara D; Rytting ME; Wang S; Abdelall W; Konoplev SN; Daver NG
Cancer; 2016 Sep; 122(18):2857-66. PubMed ID: 27244347
[TBL] [Abstract][Full Text] [Related]
35. Unexpected Findings in a Child with Atypical Hemolytic Uremic Syndrome: An Example of How Genomics Is Changing the Clinical Diagnostic Paradigm.
Seaby EG; Gilbert RD; Andreoletti G; Pengelly RJ; Mercer C; Hunt D; Ennis S
Front Pediatr; 2017; 5():113. PubMed ID: 28589114
[No Abstract] [Full Text] [Related]
36. Hemophagocytic Lymphohistiocytosis Complicating Systemic Sarcoidosis.
Abughanimeh O; Qasrawi A; Abu Ghanimeh M
Cureus; 2018 Jun; 10(6):e2838. PubMed ID: 30131931
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Problems in Chronic Basophilic Leukemia.
Çehreli C
Turk J Haematol; 2018 Nov; 35(4):283-289. PubMed ID: 30401657
[TBL] [Abstract][Full Text] [Related]
38. CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
Watanabe J; Sato K; Osawa Y; Horiuchi T; Kato S; Hikota-Saga R; Maekawa T; Yamamura T; Kobayashi A; Kobayashi S; Kimura F
Int J Hematol; 2018 Jul; 108(1):47-57. PubMed ID: 29600428
[TBL] [Abstract][Full Text] [Related]
39. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
40. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
